# Precision Medicine 
1. [Introduction](#1)
2. [Asthma](#2)<br>
    2.1 [Application to Precision Medicine](#21)<br>
    2.2 [subtitle2](#2322)
3. [Application to Precision Medicine](#3)
4. [title 4](#234)
5. [title 5](#235)




## 1. Introduction<a name="1"></a>

The reason why Precision Medicine is such a hot topic is because it essentially defines a new medical model; one that utilizes factors such as an individual's environment as well as there genetic makeup in order to determine medical decisions, practices, interventions, and products. It recognizes that a disease may be characterized by a similar set of symptoms - yet the mechanisms behind those symptoms may differ from person to person. 

Here is a brief introductory video about the concept of Precision Medicine [1]:

[![IMAGE ALT TEXT HERE](https://img.youtube.com/vi/HQKFgfMO5Sw/0.jpg)](https://www.youtube.com/watch?v=HQKFgfMO5Sw)

## 2. Asthma<a name="2"></a>





#### 2) Through-put and resolution<a name="2322"></a>
Hi-C techniques has the highest through-put (billion reads per sample) but suffering of a relative low resolution of 0.1-1Mb. However, the other methods usually have a higher resolution  around 1kb. For more details one can refer to table2 in [2].

## 3. Application to Precision Medicine<a name="3"></a>
#### 1) Phenotype Classification<a name="21"></a>

![](/figure1.png)<br>
[Figure1](https://insights.ovid.com/pubmed?pmid=29045293). Clinical phenotypes of moderate–severe asthma derived from U-BIOPRED cohort from a cluster analysis of eight clinico-physiologic parameters. **Figure by Kian Fan Chung. Current Opinion in Pulmonary Medicine (2018).**


##### Hi-C critical steps [8] 
- Fixation: keep DNA conformed
- Digestion: enzyme frequency and penetratin
- Fill-in: biotin for junction enrichment
- Ligation: freeze interactions in sequence
- Biotin removal: junctions only
- Fragment size: small fragments sequence better
- Adapter ligation: paired-end and indexing
- PCR: create enough material for flow cell

##### Hi-C derived techniques 
- Hi-C original: [Lieberman-Aiden et al., Science 2010](doi: 10.1126/science.1181369)
- Hi-C 1.0: [Belton-JM et al., Methods 2012](doi: 10.1016/j.ymeth.2012.05.001)
- In situ Hi-C: [Rao et al., Cell 2014](doi: 10.1016/j.cell.2014.11.021)
- Single cell Hi-C: [Nagano et al., Genome Biology 2015](https://doi.org/10.1186/s13059-015-0753-7)
- DNase Hi-C [Ma, Wenxiu, Methods et al](https://www.ncbi.nlm.nih.gov/pubmed/25437436)
- Hi-C 2.0: [Belaghzal et al., Methods 2017](https://www.ncbi.nlm.nih.gov/pubmed/28435001)
- DLO-Hi-C: [Lin et al., Nature Genetics 2018](https://doi.org/10.1038/s41588-018-0111-2)
- Hi-C improving: [Golloshi et al., Methods 2018](https://www.biorxiv.org/content/biorxiv/early/2018/02/13/264515.full.pdf)
- Arima 1-day Hi-C: [Ghurye et al., BioRxiv 2018](https://www.biorxiv.org/content/early/2018/02/07/261149)

## 2.3.4 ChIA-PET<a name="234"></a> 
ChIA-PET is another method that combines ChIP and pair-end sequencing to analysis the chromtin interaction. It allows for targeted binding factors such as: estrogen receptor alpha, CTCF-mediated loops, RNA polymerase II, and a combination of key architectural factors. on the one hand, it has the benefit of achieving a higher resolution compared to Hi-C, as only ligation products involving the immunoprecipitated molecule are sequenced, on the other hand, ChIA-PET has systematic biases due to ChIP process:
- Only one type of binding factor selected
- Different antibodies
- ChIP conditions


## 2.3.5 Selected methods comparison<a name="235"></a> 
<table>
 <tbody>
    <tr>
        <th>Method</td>
        <th>Targets</td>
        <th>Resolution</td>
        <th>Notes</td>
    </tr>
    <tr>
        <td>3C <a href="http://refhub.elsevier.com/S2001-0370(17)30093-4/rf0535">[3]</a></td>
        <td>one-vs-one</td>
        <td>~1–10 kb<br></td>
        <td><ul><li>Sequence of bait locus must be known</li><li>Easy data analysis</li><li>Low throughput</li></ul></td>
    </tr>
    <tr>
    <td>4C <a href="http://refhub.elsevier.com/S2001-0370(17)30093-4/rf0545">[4]</a></td>
    <td>one-vs-all</td>
    <td>~2 kb</td>
    <td><ul><li>Sequence of bait locus must be known</li><li>Detects novel contacts</li><li>Long-range contacts</li></ul></td>
    </tr>
    <tr>
    <td>5C <a href="http://refhub.elsevier.com/S2001-0370(17)30093-4/rf0550">[5]</a></td>
    <td>many-vs-many</td>
    <td>~1 kb</td>
    <td><ul><li>High dynamic range</li><li>Complete contact map of a locus</li><li>3C with ligation-mediated amplification (LMA) of a ‘carbon copy’ library of oligos designed across restriction fragment junctions of interest
3C</li></ul></td>
    </tr>
    <tr>
    <td>Hi-C <a href="http://refhub.elsevier.com/S2001-0370(17)30093-4/rf0300">[6]</a></td>
    <td>all-vs-all</td>
    <td>0.1–1 Mb</td>
    <td><ul><li>Genome-wide nucleosome core positioning</li><li>Relative low resolution</li><li>High cost</li></ul></td>
    </tr>
    <tr>
    <td>ChIA-PET <a href="http://refhub.elsevier.com/S0168-9525(15)00063-3/sbref1405">[7]</a></td>
    <td>Interaction of whole genome mediated by protein</td>
    <td>Depends on read depth and the size of the genome region bound by the protein of interest</td>
    <td><ul><li>Lower noise with ChIP</li><li>Biased method since selected protein</li></ul></td>
    </tr>
 </tbody>
</table>

















# Referrence
[1] (UCSF), UC San Francisco, director. What Is Precision Medicine? YouTube, YouTube, 2 Dec. 2015, www.youtube.com/watch?v=HQKFgfMO5Sw.<br>

[2] Chung, Kian Fan. “Precision Medicine in Asthma.” Current Opinion in Pulmonary Medicine, vol. 24, no. 1, 1 Jan. 2018, pp. 4–10., doi:10.1097/mcp.0000000000000434.<br>

[3] Seumois, Grégory et al. “Transcriptional Profiling of Th2 Cells Identifies Pathogenic Features Associated with Asthma” Journal of immunology (Baltimore, Md. : 1950) vol. 197,2 (2016): 655-64. <br>

[4] <br>

[5] <br>

[6] <br>

[7] <br>

[8] 

